Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Experimental vaccine aims to stop cancer from coming back

NCT ID NCT07353645

Summary

This study is testing a personalized vaccine designed to train the immune system to recognize and attack cancer cells. It's for people with colorectal or pancreatic cancer who have had surgery but are at high risk of the cancer returning. The goal is to see if the vaccine is safe and can help prevent the cancer from coming back.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PANCREATIC CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Nanjing Drum Tower Hospital Affiliated to Medical School of Nanjing University

    RECRUITING

    Nanjing, Jiangsu, 210008, China

    Contact Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.